Ullman Quoted in Natural Products Insider Article

Marc Ullman was quoted in a Natural Products Insider article entitled, “FDA Triggered Industry Shift from ‘CBD’ to ‘Hemp Extracts’ in Dietary Supplements.” The article addresses the point that amid the escalating demands for CBD in the United States, many companies are selling “hemp extracts,” a strategy based on regulatory and scientific considerations.”

“If you’re showing elevated levels of CBD, that means you’re manipulating the product for CBD content,” said Ullman. “That a ‘hemp extract’ may include other cannabinoids besides CBD won’t resolve FDA’s concerns if the amount of CBD detected in the product is higher than what’s found in nature, Ullman suggested. “It’s like red yeast rice,” he said. “You can have … naturally occurring lovastatin at extremely low levels, and also have other statins in there that are naturally occurring … in the red yeast rice. And just because you have those other statins present that are naturally occurring doesn’t save you if you also have elevated levels of lovastatin.”

Click here to read entire article.